Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02262910
Title Study of MOR209/ES414 in Metastatic Castration-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Aptevo Therapeutics
Indications

prostate adenocarcinoma

Therapies

MOR209/ES414

Age Groups: adult | senior | child
Covered Countries USA


No variant requirements are available.